Clinical study of the necessity of replanning before the 20th fraction during the course of intensity modulated radiotherapy for patients with nasopharyngeal carcinoma

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-13004018

Enrollment

Unknown

Registered

2013-12-16

Start date

2012-07-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

nasopharyngeal carcinoma

Interventions

A:Intensity modulated radiotherapy with replanning before the 20th fraction

B:Intensity modulated radiotherapy without replanning before the 20th fraction

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) All patients should sign an institutional review board (IRB)approved consent form; (2) Irrespective of sex, patient should be between 18 and 75 years old; (3) Pathologically confirmed nasopharyngeal carcinoma; (4) With a Karnofsky performance status of at least 70% and expected survival of longer than 6 months;

Exclusion criteria

Exclusion criteria: (1) Previous surgical resection of the primary tumor or positive lymph node(s); (2) Prior radiotherapy or of the primary tumor or lymph node regions; (3) Prior chemotherapy within one month; (4) Refused or unable to sign an institutional review board (IRB) approved consent form; (5) With expected survival of less than 6 months.

Design outcomes

Primary

Measure	Time frame
Acute and late toxicity;Local recurrence rate;Overall survival;	—

Countries

China

Contacts

Public ContactLinchun Feng

Chinese PLA General Hospital

301flc@outlook.com+86 15910926073

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026